FDA Inspection 972378 — Neo Vision Co Ltd

Neo Vision Co Ltd — FEI 3009674807

The FDA completed an inspection of Neo Vision Co Ltd on May 12, 2016 in Yongin. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 5 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
May 12, 2016
Fiscal Year
2016
Product Type
Devices
Project Area
Compliance: Devices
Location
Yongin (Korea (the Republic of))

Citations

IDCFRDescription
237121 CFR 820.30(a)Design control - no procedures
316021 CFR 820.184Lack of or inadequate DHR procedures
368021 CFR 820.70(a)Process control procedures, Lack of or inadequate procedures
53721 CFR 820.70(a)Production processes
63021 CFR 803.17Lack of Written MDR Procedures